 Your new post is loading...
 Your new post is loading...
Une nouvelle IA analyse une seule nuit de sommeil pour prédire des maladies des années avant leur apparition.
2023 a été l’année de naissance des chabots, 2024, celle de leur consécration. De même, 2025 a été l’année de naissance des agents intelligents, et 2026 sera également l’année de leur consécration, car elle va aller de paire avec l’avènement de la super-intelligence. Cette montée en puissance se traduira par des changements majeurs dans notre … Lire la suite Web agentique : la révolution qui ne vous attendra pas →
Les outils numériques (smartphone, bientôt couplés aux wearables) peuvent affiner l’évaluation des traitements de l’insomnie, en mettant la journée au centre du suivi, et pas seulement la nuit
Anthropic and Google are the latest major players to announce AI tools designed for healthcare, following the launch of ChatGPT Health.
AI is central to the World Economic Forum’s MINDS programme, recognizing companies using AI for real-world impact, with an insights report and a forthcoming third cohort.
10.1016/j.annonc.2025.11.014
February 24, 2025 AI Is in the Doctor’s Bag—And Primary Care Is Ready to Use It Thank you to the American Academy of Family Physicians (AAFP) for their support and collaboration, with special gratitude to Shawn Martin; Steven Waldren, MD; Karen Johnson, PhD; Kathy Reid, PhD; and Bethany Burk.
The chronic condition management company’s debut comes weeks after another digital health company, Hinge Health, went public. The IPOs are a “promising bellwether” for the sector, one expert said.
EXCLUSIF. Le baromètre In Extenso sur les levées de fonds révèle un décrochage des investissement dans les start-up en France, en particulier dans le secteur de la santé. Face à des investisseurs désormais plus pragmatiques, la « HealthTech » française est à la recherche de nouveaux relais d'investissements.
Healthcare doesn’t fail at AI because of bad models. It fails because the enterprise isn’t ready to trust, govern or operationalize them.
The Medical Futurist Webicina Kft. © 2026 Privacy Policy What we do Magazine Courses Research Books Keynotes Who we are Dr. Bertalan Mesko The Medical Futurist Institute Team Vision Impact Contact
Via Emmanuel Capitaine
|
Artificial intelligence (AI) has quietly become one of the most widely used entry points into the healthcare system. According to OpenAI’s January 2026
Les inquiétudes concernant la confidentialité des données et les hallucinations n'empêchent pas le secteur de la santé d'adopter l'automatisation.
Incidents arising from use of the technology, such as deepfake-enabled scams and chatbot-induced delusions have been rising steadily.
Large language models (LLMs) like ChatGPT can write an essay or plan a menu almost instantly. But until recently, it was also easy to stump them. The models, which rely on language patterns to respond to users' queries, often failed at math problems and were not good at complex reasoning. Suddenly, however, they've gotten a lot better at these things.
See how health systems can leverage generative AI to measure value, boost efficiency, and bridge the tech gap across care and workforce.
Rock Health provided a list of the biggest capital raises of 2025.
OpenAI, Google, and Anthropic launched medical AI diagnostics tools within seven days, but none are cleared for clinical use despite healthcare transformation claims.
While health systems will continue their AI rollout, use of the technology could evolve amid intensifying competition from EHRs, fragmented regulations and growing M&A opportunities.
Via Emmanuel Capitaine
Improved performance for medical imaging use cases MedGemma was designed from the ground up as a multimodal model, reflecting the multimodal nature of medicine. MedGemma 1 included support for interpreting two-dimensional medical images, including chest X-rays, dermatology images, fundus images...
L'objectif est d'identifier les gènes en lien avec les maladies cardiaques afin de proposer plus rapidement des soins personnalisés.
|
The U.S. Department of Health and Human Services and the American Society of Nephrology announced a $10 million prize this past week to accelerate the development of artificial kidneys toward human trials.